Literature DB >> 24610928

All of the twos, 22-bingo!

Andrew J Rees1.   

Abstract

Keywords:  acute renal failure; interleukin-22; ischemia reperfusion

Mesh：

Substances：

Year:  2014        PMID： 24610928      PMCID： PMC4005322          DOI： 10.1681/ASN.2014020138

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  23 in total

1.  IL-22 induces an acute-phase response.

Authors:  Spencer C Liang; Cheryl Nickerson-Nutter; Debra D Pittman; Yijun Carrier; Debra G Goodwin; Kathleen M Shields; Andre-Jean Lambert; Scott H Schelling; Quintus G Medley; Hak-Ling Ma; Mary Collins; Kyriaki Dunussi-Joannopoulos; Lynette A Fouser
Journal:  J Immunol       Date:  2010-09-24       Impact factor: 5.422

2.  Toll-like receptor 4-induced IL-22 accelerates kidney regeneration.

Authors:  Onkar P Kulkarni; Ingo Hartter; Shrikant R Mulay; Jan Hagemann; Murthy N Darisipudi; Santhosh Kumar Vr; Simone Romoli; Dana Thomasova; Mi Ryu; Sebastian Kobold; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 10.121

Review 3.  Interleukin-22: a likely target for treatment of autoimmune diseases.

Authors:  Xuyan Yang; Song Guo Zheng
Journal:  Autoimmun Rev       Date:  2014-01-10       Impact factor: 9.754

Review 4.  Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

Authors:  Gregory F Sonnenberg; Lynette A Fouser; David Artis
Journal:  Nat Immunol       Date:  2011-05       Impact factor: 25.606

5.  Cutting edge: immune cells as sources and targets of the IL-10 family members?

Authors:  Kerstin Wolk; Stefanie Kunz; Khusru Asadullah; Robert Sabat
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

6.  Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.

Authors:  Stefanie Eyerich; Kilian Eyerich; Davide Pennino; Teresa Carbone; Francesca Nasorri; Sabatino Pallotta; Francesca Cianfarani; Teresa Odorisio; Claudia Traidl-Hoffmann; Heidrun Behrendt; Stephen R Durham; Carsten B Schmidt-Weber; Andrea Cavani
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

7.  Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.

Authors:  Diane Lejeune; Laure Dumoutier; Stefan Constantinescu; Wiebe Kruijer; Jan Jacob Schuringa; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

8.  IL-22 increases the innate immunity of tissues.

Authors:  Kerstin Wolk; Stefanie Kunz; Ellen Witte; Markus Friedrich; Khusru Asadullah; Robert Sabat
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

9.  Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid.

Authors:  J C J Martin; G Bériou; M Heslan; C Chauvin; L Utriainen; A Aumeunier; C L Scott; A Mowat; V Cerovic; S A Houston; M Leboeuf; F X Hubert; C Hémont; M Merad; S Milling; R Josien
Journal:  Mucosal Immunol       Date:  2013-05-08       Impact factor: 7.313

10.  IL-22 is related to development of human colon cancer by activation of STAT3.

Authors:  Runqiu Jiang; Haiyang Wang; Lei Deng; Jiajie Hou; Ruihua Shi; Ming Yao; Yun Gao; Aihua Yao; Xuehao Wang; Lianzhen Yu; Beicheng Sun
Journal:  BMC Cancer       Date:  2013-02-05       Impact factor: 4.430
View more
  1 in total

1.  Interleukin-22 Attenuated Renal Tubular Injury in Aristolochic Acid Nephropathy via Suppressing Activation of NLRP3 Inflammasome.

Authors:  Shaofei Wang; Jiajun Fan; Xiaobin Mei; Jingyun Luan; Yubin Li; Xuyao Zhang; Wei Chen; Yichen Wang; Guangxun Meng; Dianwen Ju
Journal:  Front Immunol       Date:  2019-09-24       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.